Company Name:argenx SE
CEO: Tim Van Hauwermeiren

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: argenx SE, along with its subsidiaries is engaged in the bio-technical research on drugs and pharma processes for the treatment of oncological, autoimmune and inflammatory diseases.


Key numbers

Market Capitalization:5311042275
Shares Outstanding: 38107500
Float: 37935254.1
Next Earning Date:2020-02-27
TTm EPS: -2.9323
TTm Dividend Rate:
200 days moving average:127.77
50 days moving average: 120.44
One day percent Change: 22.25



2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30,
2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,